Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIOP Intracranial Germ Cell Tumours Protocol
NCT00293358Phase 3Completed
- Sponsor
- Children's Cancer and Leukaemia Group
- Start
- Jan 1997
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 3 trial of carboplatin, cisplatin, etoposide phosphate, ifosfamide in intracranial germ cell tumor (ICGCT), sponsored by Children's Cancer and Leukaemia Group. Started Jan 1997; status: completed.
02
Drugs
carboplatincisplatinetoposide phosphateifosfamide
03
Conditions
intracranial germ cell tumor (ICGCT)
Beyond the preview
Go deeper on NCT00293358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293358.